Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis.

Neurol Genet

ALS Center (M.G., G.B., G.D.M., F.C., G.F., P.S., P.C., A.B., R.V., U.M., Antonio Canosa, C.M., Andrea Calvo, Adriano Chio), ''Rita Levi Montalcini'' Department of Neuroscience, University of Turin, Italy; Neuromuscular Diseases Research Section (M.G., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Porter Neuroscience Research Center, Bethesda, MD; Laboratory of Genetics (M.B., L.S.), Department of Clinical Pathology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino; S.C. Neurologia 1U (S.G., U.M., Antonio Canosa, C.M., Andrea Calvo, Adriano Chio), Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; Reta Lila Weston Institute (B.J.T.), UCL Queen Square Institute of Neurology, University College London, United Kingdom; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore; National Institute of Neurological Disorders and Stroke (B.J.T.), NIH, Bethesda; ASO Rapid Development Laboratory (B.J.T.), Therapeutics Development Branch, National Center for Advancing Translational Sciences, NIH, Rockville, MD; and Institute of Cognitive Sciences and Technologies (Adriano Chio), National Council of Research, Rome, Italy.

Published: October 2022

Background And Objectives: Pathogenic variations in fused in sarcoma are among the most common genetic causes of amyotrophic lateral sclerosis (ALS) worldwide. They are supposedly characterized by a homogeneous pure motor phenotype with early-onset and short disease duration. However, a few mutated cases with a very late disease onset and slow progression have been reported. To analyze genotype-phenotype correlations and identify the prognostic factors in -ALS cases.

Methods: We identified and cross-sectionally analyzed 22 -ALS patient histories from a single-center cohort of 2,615 genetically tested patients and reviewed 289 previously published -ALS cases. Survival analysis was performed by Kaplan-Meier survival curves, followed by the log-rank test and multivariate Cox analysis.

Results: Survival of -ALS is age-dependent: In our cohort, early-onset cases had a rapid disease progression and short survival ( = 0.000003) while the outcome of -mutated patients with mid-to-late onset did not differ from non--ALS patients ( = 0.437). Meta-analysis of literature data confirmed this trend ( = 0.00003). This survival pattern is not observed in other ALS-related genes in our series. We clustered -ALS patients in 3 phenotypes: (1) axial ALS, with upper cervical and dropped-head onset in mid-to-late adulthood; (2) benign ALS, usually with a late-onset and slow disease progression; and (3) juvenile ALS, often with bulbar onset and preceded by learning disability or mild mental retardation. Those phenotypes arise from different mutations.

Discussion: We observed specific genotype-phenotype correlations of -ALS and identified age at onset as the most critical prognostic factor. Our results demonstrated that mutations underlie a specific subtype of ALS and enable a careful stratification of newly diagnosed -ALS cases for clinical course and potential therapeutic windows. This will be crucial in the light of incoming gene-specific therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469212PMC
http://dx.doi.org/10.1212/NXG.0000000000200011DOI Listing

Publication Analysis

Top Keywords

fused sarcoma
8
amyotrophic lateral
8
lateral sclerosis
8
genotype-phenotype correlations
8
-als cases
8
disease progression
8
-als
7
als
5
onset
5
survival
5

Similar Publications

Proteostasis is maintained through regulated protein synthesis and degradation and chaperone-assisted protein folding. However, this is challenging in neuronal projections because of their polarized morphology and constant synaptic proteome remodeling. Using high-resolution fluorescence microscopy, we discover that hippocampal and spinal cord motor neurons of mouse and human origin localize a subset of chaperone mRNAs to their dendrites and use microtubule-based transport to increase this asymmetric localization following proteotoxic stress.

View Article and Find Full Text PDF

Fused in sarcoma (FUS) is a causative factor of amyotrophic lateral sclerosis (ALS) and is believed to propagate pathologically by transmission from cell to cell. However, the mechanism underlying FUS release from cells, which is a critical step for the propagation system, remains poorly understood. This study conducted an analysis of the release of human and mouse FUS from neurons, revealing that human FUS is significantly released into the media compared to its mouse counterpart.

View Article and Find Full Text PDF

Background: Bladder cancer (BC) is a malignant tumor that begins in the cells of the bladder, characterized by poor cell differentiation and strong invasion capacity, with a high incidence rate. Identifying key molecules that enhance BC cells' cisplatin sensitivity can help improve the clinical efficacy of BC treatment. Hence, this study aimed to determine the expression level of long non-coding RNA (lncRNA) ADAM Metallopeptidase with Thrombospondin Type 1 Motif 9 Antisense RNA 1 () in BC and explore its related mechanism underlying the amplification of cisplatin sensitivity.

View Article and Find Full Text PDF

Background: Primary squamous cell carcinoma (SCC) of the middle ear is rare, with non-keratinizing basaloid types being exceptionally uncommon. Distinguishing these cancers, often caused by viral factors (, human papillomavirus or Epstein-Barr virus), or specific genetic alterations (, bromodomain-containing protein 4-nuclear protein in or gene fused with FLI chromosomal rearrangement), from other cranial conditions, is difficult. The recently identified DEK::AFF2 non-keratinizing SCC (NKSCC) is a novel subtype, fitting the World Health Organization classification of head and neck neoplasms.

View Article and Find Full Text PDF

Mitochondrial dysfunction plays a pivotal role in the progression of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. Recent discoveries have highlighted the involvement of DNA damage and repair processes, particularly mitochondrial DNA (mtDNA) damage, in these conditions. This commentary reflects on our recent findings, demonstrating the RNA/DNA binding protein fused in sarcoma (FUS)'s crucial role in maintaining mtDNA integrity through interactions with mitochondrial DNA ligase IIIα (mtLig3).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!